Venous Insufficiency

• FDA approval · 2019-05-22
  FDA Approved: SOTRADECOL — Supplemental Application (Mylan Institutional LLC)

  FDA approved a supplemental application for SOTRADECOL (sodium tetradecyl sulfate) submitted by Mylan Institutional LLC under an ANDA.

• FDA approval · 2016-06-23
  FDA Approved: VARITHENA — Supplemental Application (Biocompatibles, Inc.)

  The FDA approved a supplemental application for Varithena (polidocanol) submitted by Biocompatibles, Inc., relating to its approved product …

• FDA approval · 2016-03-04
  FDA Approved: VARITHENA — Supplemental Application (Biocompatibles, Inc.)

  FDA approved a supplemental application for Varithena (polidocanol) from Biocompatibles, Inc., to update the labeling with approved uses for…

• FDA approval · 2016-01-21
  FDA Approved: VARITHENA — Supplemental Application (Biocompatibles, Inc.)

  The FDA approved a supplemental application for Varithena (polidocanol) submitted by Biocompatibles, Inc.

• FDA approval · 2015-04-23
  FDA Approved: VARITHENA — Supplemental Application (Biocompatibles, Inc.)

  FDA approved a supplemental application for Varithena (polidocanol) from Biocompatibles, Inc., representing an additional regulatory action …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2015-01-08
  FDA Approved: VARITHENA — Supplemental Application (Biocompatibles, Inc.)

  FDA approved a supplemental application for Varithena (polidocanol) from Biocompatibles, expanding its approved use for treatment of varicos…

• FDA approval · 2013-11-25
  FDA Approved: VARITHENA — Original Application (Biocompatibles, Inc.)

  FDA approved Varithena (polidocanol) as an original application for the treatment of varicose veins of the leg due to incompetent great saph…